Investment Newsletter Disclaimer

Diabetic Investor provides a newsletter and other audio, audio-visual, and other content, containing independent analysis of the business of diabetes. Diabetic Investor is not paid by any company to recommend a product or service, or to recommend a stock to investors. We are completely independent.

The information provided by Diabetic Investor is obtained from sources believed to be reliable but is not guaranteed as to accuracy or completeness. Subscribers to the Diabetic Investor Newsletter, or any other persons who buy, sell or hold securities should do so with caution and consult with a broker or investment adviser before doing so.

The information contained in the Diabetic Investor Newsletter is provided for general informational purposes, as a convenience to subscribers. The materials are not a substitute for obtaining professional advice from a qualified professional. Consult the appropriate advisor for more complete and current information. Diabetic Investor is not engaged in rendering any investment advice, legal, or other professional services, by providing these general informational materials and the publisher specifically disclaims any liability, whether based in contract, tort, strict liability or otherwise, for any direct, indirect, incidental, consequential, or special damages arising out of or in any way connected with access to or use of information provided in the Diabetic Investor Newsletter, even if Diabetic Investor has been advised of the possibility of such damages, including liability in connection with mistakes or omissions in, or delays in transmission of, information to or from the user, interruptions in telecommunications connections to the site or viruses.